Dendrimer toxicity: Let's meet the challenge

被引:517
作者
Jain, Keerti [1 ]
Kesharwani, Prashant [1 ]
Gupta, Umesh [1 ]
Jain, N. K. [1 ]
机构
[1] Dr HS Gour Univ Sagar MP, Dept Pharmaceut Sci, Pharmaceut Res Lab, Sagar 470003, India
关键词
Dendrimers; Cationic toxicity; Biocompatibility; Surface engineering; TUFTSIN-BEARING LIPOSOMES; POLYAMIDOAMINE PAMAM DENDRIMERS; CELL-MEMBRANE DISRUPTION; SUPPORTED LIPID-BILAYERS; CO-POLYESTER DENDRIMERS; IN-VIVO TOXICITY; DRUG-DELIVERY; BIOLOGICAL EVALUATION; PEPTIDE DENDRIMERS; GENE DELIVERY;
D O I
10.1016/j.ijpharm.2010.04.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dendrimers are well-defined, versatile polymeric architecture with properties resembling biomolecules. Dendritic polymers emerged as outstanding carrier in modern medicine system because of its derivatisable branched architecture and flexibility in modifying it in numerous ways. Dendritic scaffold has been found to be suitable carrier for a variety of drugs including anticancer, anti-viral, anti-bacterial, antitubercular etc., with capacity to improve solubility and bioavailability of poorly soluble drugs. In spite of extensive applicability in pharmaceutical field, the use of dendrimers in biological system is constrained because of inherent toxicity associated with them. This toxicity is attributed to the interaction of surface cationic charge of dendrimers with negatively charged biological membranes in vivo. Interaction of dendrimers with biological membranes results in membrane disruption via nanohole formation, membrane thinning and erosion. Dendrimer toxicity in biological system is generally characterized by hemolytic toxicity, cytotoxicity and hematological toxicity. To minimize this toxicity two strategies have been utilized; first, designing and synthesis of biocompatible dendrimers; and second, masking of peripheral charge of dendrimers by surface engineering. Biocompatible dendrimers can be synthesized by employing biodegradable core and branching units or utilizing intermediates of various metabolic pathways. Dendrimer biocompatibility has been evaluated in vitro and in vivo for efficient presentation of biological performance. Surface engineering masks the cationic charge of dendrimer surface either by neutralization of charge, for example PEGylation, acetylation, carbohydrate and peptide conjugation; or by introducing negative charge such as half generation dendrimers. Neutral and negatively charged dendrimers do not interact with biological environment and hence are compatible for clinical applications as elucidated by various studies examined in this review. Chemical modification of the surface is an important strategy to overcome the toxicity problems associated with the dendrimers. The present review emphasizes on the approaches available to overcome the cationic toxicity inherently associated with the dendrimers. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码:122 / 142
页数:21
相关论文
共 144 条
[1]   Tumour and dendrimers: a review on drug delivery aspects [J].
Agarwal, Abhinav ;
Asthana, Abhay ;
Gupta, Umesh ;
Jain, Narendra K. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (06) :671-688
[2]   Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent [J].
Agarwal, Abhinav ;
Gupta, Umesh ;
Asthana, Abhay ;
Jain, Narendra K. .
BIOMATERIALS, 2009, 30 (21) :3588-3596
[3]   Investigations on the toxicological profile of functionalized fifth-generation poly(propylene imine) dendrimer [J].
Agashe, Hrushikesh B. ;
Dutta, Tathagata ;
Garg, Minakshi ;
Jain, N. K. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (11) :1491-1498
[4]   Tuftsin-bearing liposomes in treatment of macrophage-based infections [J].
Agrawal, AK ;
Gupta, CM .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (02) :135-146
[5]   Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters [J].
Agrawal, AK ;
Agrawal, A ;
Pal, A ;
Guru, PY ;
Gupta, CM .
JOURNAL OF DRUG TARGETING, 2002, 10 (01) :41-45
[6]   Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate [J].
Agrawal, Payal ;
Gupta, Umesh ;
Jain, N. K. .
BIOMATERIALS, 2007, 28 (22) :3349-3359
[7]  
Amiji M.M., 2006, Nanotechnology for Cancer Therapy, DOI DOI 10.1201/9781420006636
[8]  
[Anonymous], CURR PROTOC IMMUNOL
[9]   Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient [J].
Asthana, A ;
Chauhan, AS ;
Diwan, PV ;
Jain, NK .
AAPS PHARMSCITECH, 2005, 6 (03)
[10]   Dendrimers: a new class of nanoscopic containers and delivery devices [J].
Aulenta, F ;
Hayes, W ;
Rannard, S .
EUROPEAN POLYMER JOURNAL, 2003, 39 (09) :1741-1771